Straumins Jennifer 4
4 · Calumet, Inc. /DE · Filed Jul 12, 2024
Insider Transaction Report
Form 4
Straumins Jennifer
Director
Transactions
- Other
Warrants to purchase Common Stock
2024-07-10+300,000→ 300,000 totalExercise: $20.00From: 2024-07-10Exp: 2027-07-10→ Common Stock, par value $0.01 per share (300,000 underlying) - Other
Common Stock, par value $0.01 per share
2024-07-10+825,000→ 1,488,529 total
Footnotes (2)
- [F1]On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC ("Merger Sub I") merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). Pursuant to the GP Merger, all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5,500,000 shares of Calumet, Inc. common stock, par value $0.01 per share (the "Common Stock"), and 2,000,000 warrants to purchase Common Stock (the "Warrants"). In connection with the GP Merger, the reporting person was issued 825,000 shares of Common Stock and 300,000 Warrants.
- [F2]The reporting person disclaims beneficial ownership of all shares of Common Stock reported herein, except to the extent of any pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.